Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A site-wide NIH notice announces a transition update and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.3%
    Check dated 2026-10-24T11:31:25.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer now identifies the site as running revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-17T12:39:22.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-10T13:06:48.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The study record history continues to show the trial’s version list and the sections updated in each version.
    Difference
    0.0%
    Check dated 2026-10-03T14:17:34.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision history updated: a new entry 'Revision: v3.7.0' has been added and an older entry 'Revision: v3.6.6' removed, reflecting the latest version in the study record history.
    Difference
    0.0%
    Check dated 2026-09-19T18:11:38.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The record history now includes updates for Study Design, Study Status, and Recruitment Status, reflecting new structured status information for the trial. The study's status has been changed from Active, not recruiting to Completed.
    Difference
    0.3%
    Check dated 2026-08-29T18:55:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.